Alto Neuroscience (ANRO) Interest & Investment Income (2023 - 2026)

Alto Neuroscience's (ANRO) quarterly Interest & Investment Income came in at $1.6 million in Q1 2026, down 14.56% year-on-year from $1.8 million in Q1 2025, and little changed quarter-over-quarter from $1.6 million in Q4 2025.

Alto Neuroscience (ANRO) Interest & Investment Income (2023 - 2026) Analysis & Trends

Alto Neuroscience has disclosed Interest & Investment Income across 4 years of filings, most recently posting $1.6 million for Q1 2026.

  • Interest & Investment Income for Q1 2026 came in at $1.6 million, down 14.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.3 million (down 30.52% YoY), and the FY2025 annual result was $6.6 million, down 25.4% from the prior year.
  • Interest & Investment Income came in at $1.6 million for Q1 2026 at Alto Neuroscience, roughly flat from $1.6 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $2.7 million in Q2 2024 to a low of $230000.0 in Q1 2023.
  • The 4-year median for Interest & Investment Income is $1.6 million (2025), against an average of $1.5 million.
  • Across the five-year window, Interest & Investment Income jumped 577.39% in 2024 and sank 38.72% in 2025, its largest moves.
  • Alto Neuroscience's Interest & Investment Income stood at $738000.0 in 2023, then soared by 189.3% to $2.1 million in 2024, then retreated by 26.89% to $1.6 million in 2025, then changed by 0.0% to $1.6 million in 2026.
  • The last three Interest & Investment Income figures came in at $1.6 million (Q1 2026), $1.6 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 597,319.59
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 40.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 305,000.00
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 103,341.00
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 114.80 Mn
9 Abivax 91.71 Bn 91.71 Bn - -14.79 Mn
10 Alto Neuroscience 643.06 Mn 379.30 Mn - 1.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.56 Mn
Dec 31, 2025 1.56 Mn
Sep 30, 2025 1.53 Mn
Jun 30, 2025 1.68 Mn
Mar 31, 2025 1.83 Mn
Dec 31, 2024 2.14 Mn
Sep 30, 2024 2.50 Mn
Jun 30, 2024 2.66 Mn
Mar 31, 2024 1.56 Mn
Dec 31, 2023 738,000.00
Sep 30, 2023 714,000.00
Jun 30, 2023 667,000.00
Mar 31, 2023 230,000.00